2024-03-05 21:29:08 ET
NeuroPace, Inc. (NPCE)
Q4 2023 Earnings Conference Call
March 05, 2024 4:30 PM ET
Company Participants
Jeremy Feffer – Managing Director, LifeSci Advisors
Joel Becker – Chief Executive Officer
Rebecca Kuhn – Chief Financial Officer
Conference Call Participants
Frank Takkinen – Lake Street Capital Markets
Vik Chopra – Wells Fargo
Mike Kratky – Leerink Partners
Michael Polark – Wolfe Research
Drew Ranieri – Morgan Stanley
Presentation
Operator
Good afternoon, and welcome to NeuroPace’s Fourth Quarter and Year-End 2023 Earnings Conference Call. As a reminder, this conference is being recorded. I would now like to turn the call over to Jeremy Feffer from LifeSci Advisors for a few introductory comments.
Jeremy Feffer
Good afternoon. Thank you for joining us for NeuroPace’s fourth quarter and year-end 2023 financial and operating results conference call. On today’s call, we will hear from Joel Becker, Chief Executive Officer; and Rebecca Kuhn, Chief Financial Officer.
Earlier today, NeuroPace released financial results for the fourth quarter and year-ended December 31, 2023. A copy of the press release is available on the company’s website at neuropace.com.
Before we begin, I would like to remind you that throughout this call, we will make statements that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.
All forward-looking statements, including those around NeuroPace’s projections, business opportunities, commercial expansion, market conditions, clinical trials and those relating to our operating trends and future financial performance, expense management, estimates of market opportunity and forecasted market and revenue growth are based on current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements....
Read the full article on Seeking Alpha
For further details see:
NeuroPace, Inc. (NPCE) Q4 2023 Earnings Call Transcript